The study is a follow-up of a randomized controlled study performed in 2011-2012 with medication reviews in elderly patients in Sweden. Additional data about mortality and hospital admissions have been collected.
Background Drug-related problems among the elderly population are common and increasing. Multi-professional medication reviews (MR) have arisen as a method to optimize drug therapy for frail elderly patients. Research has not yet been able to show conclusive evidence of the effect of MRs on mortality or hospital admissions. Aim The aim of this study was to assess the impact of MRs' on hospital admissions and mortality after six and 12 months in a frail population of 369 patients in primary care in a randomized controlled study. Methods Patients were blindly randomized to an intervention group (receiving MRs) and a control group (receiving usual care). Descriptive data on mortality and hospital admissions at six and 12 months were collected. Survival analysis was performed for time to death and time to the first hospital admission within 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Enrollment
369
Multi-professional medication review
hospital admission
time to the first hospital admission
Time frame: six months
hospital admission
time to the first hospital admission
Time frame: twelve months
Survival analysis
time to death
Time frame: six months
Survival analysis
time to death
Time frame: twelve months
number of hospital admissions
number of hospital admissions
Time frame: six months
number of hospital admissions
number of hospital admissions
Time frame: twelve months
mortality
number of deaths
Time frame: six months
mortality
number of deaths
Time frame: twelve months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.